UroGen Pharma (URGN) Other Gross PP&E Adjustments (2016 - 2025)
UroGen Pharma (URGN) has disclosed Other Gross PP&E Adjustments for 10 consecutive years, with -$11.1 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 13.48% year-over-year to -$11.1 million, compared with a TTM value of -$11.1 million through Dec 2025, down 13.48%, and an annual FY2025 reading of -$11.1 million, down 13.48% over the prior year.
- Other Gross PP&E Adjustments was -$11.1 million for Q4 2025 at UroGen Pharma, down from $2.1 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $4.3 million in Q1 2025 and bottomed at -$11.1 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$242400.0, with a median of $2.3 million recorded in 2022.
- The sharpest move saw Other Gross PP&E Adjustments skyrocketed 606.87% in 2021, then crashed 44.02% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at -$7.9 million in 2021, then decreased by 19.45% to -$9.5 million in 2022, then rose by 5.34% to -$9.0 million in 2023, then dropped by 8.98% to -$9.8 million in 2024, then decreased by 13.48% to -$11.1 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for URGN at -$11.1 million in Q4 2025, $2.1 million in Q3 2025, and $3.9 million in Q2 2025.